Manganese-Induced Parkinsonism and Parkinson’s Disease: Shared and Distinguishable Features
Abstract
:1. Mn Essentiality and Uses
2. Mn Toxicity
3. Occupational Mn-Induced Parkinsonism
4. Modes of Mn Transport
5. Detection and Pharmacokinetic Modeling of Mn Trafficking
6. Mn-Induced Parkinsonism and Parkinson’s Disease
7. Mn-Induced Parkinsonism and the Involvement of the Dopaminergic System
8. Mn-Induced Parkinsonism and GABA System
9. Mn-Induced Parkinsonism and Glutamate System
10. Preventive and Treatment Strategies for Mn-Induced Parkinsonism and PD
11. Conclusions
Acknowledgments
Author Contributions
Conflicts of Interest
References
- Erikson, K.M.; Syversen, T.; Aschner, J.L.; Aschner, M. Interactions between excessive manganese exposures and dietary iron-deficiency in neurodegeneration. Environ. Toxicol. Pharmacol. 2005, 19, 415–421. [Google Scholar] [CrossRef]
- Takeda, A. Manganese action in brain function. Brain Res. Rev. 2003, 41, 79–87. [Google Scholar] [CrossRef]
- Aschner, M.; Erikson, K.M.; Dorman, D.C. Manganese dosimetry: Species differences and implications for neurotoxicity. CRC Crit. Rev. Toxicol. 2005, 35, 1–32. [Google Scholar] [CrossRef]
- Pennington, J.A.; Young, B.E.; Wilson, D.B.; Johnson, R.D.; Vanderveen, J.E. Mineral content of foods and total diets: The selected minerals in foods survey, 1982 to 1984. J. Am. Diet. Assoc. 1986, 86, 876–891. [Google Scholar]
- Benedetto, A.; Au, C.; Aschner, M. Manganese-induced dopaminergic neurodegeneration: Insights into mechanisms and genetics shared with Parkinson’s disease. Chem. Rev. 2009, 109, 4862–4884. [Google Scholar] [CrossRef]
- Butterworth, J. Changes in nine enzyme markers for neurons, glia, and endothelial cells in Agonal State and Huntington’s disease caudate nucleus. J. Neurochem. 1986, 47, 583–587. [Google Scholar] [CrossRef]
- Erikson, K.M.; Aschner, M. Manganese neurotoxicity and glutamate-GABA interaction. Neurochem. Int. 2003, 43, 475–480. [Google Scholar] [CrossRef]
- Fitsanakis, V.A.; Au, C.; Erikson, K.M.; Aschner, M. The effects of manganese on glutamate, dopamine and γ-aminobutyric acid regulation. Neurochem. Int. 2006, 48, 426–433. [Google Scholar] [CrossRef]
- Hurley, L.; Keen, C.; Manganese, E.U.; Mertz, W. Trace Elements in Human Health and Animal Nutrition; Academic Press: New York, NY, USA, 1987. [Google Scholar]
- Liao, S.; Chen, C. Manganese stimulates stellation of cultured rat cortical astrocytes. Neuroreport 2001, 12, 3877–3881. [Google Scholar] [CrossRef]
- Archibald, F.S.; Tyree, C. Manganese poisoning and the attack of trivalent manganese upon catecholamines. Arch. Biochem. Biophys. 1987, 256, 638–650. [Google Scholar] [CrossRef]
- Farina, M.; Avila, D.S.; da Rocha, João Batista Teixeira; Aschner, M. Metals, oxidative stress and neurodegeneration: A focus on iron, manganese and mercury. Neurochem. Int. 2013, 62, 575–594. [Google Scholar] [CrossRef]
- Santamaria, A. Manganese exposure, essentiality & toxicity. Indian J. Med. Res. 2008, 128, 484. [Google Scholar]
- Saric, M.; Manganese, I.F.; Nordberg, G.; Vouk, V. Handbook on the Toxicology of Metals; Friberg, L., Nordberg, G.F., Vouk, V.B., Eds.; Elsevier Science Publishers B.V.: Amsterdam, The Netherlands, 1986; pp. 354–386. [Google Scholar]
- Aschner, M.; Aschner, J.L. Manganese neurotoxicity: Cellular effects and blood-brain barrier transport. Neurosci. Biobehav. Rev. 1991, 15, 333–340. [Google Scholar] [CrossRef]
- Keen, C.L.; Ensunsa, J.L.; Watson, M.H.; Baly, D.L.; Donovan, S.M.; Monaco, M.H.; Clegg, M.S. Nutritional aspects of manganese from experimental studies. Neurotoxicology 1999, 20, 213–223. [Google Scholar]
- Dobson, A.W.; Erikson, K.M.; Aschner, M. Manganese neurotoxicity. Ann. N. Y. Acad. Sci. 2004, 1012, 115–128. [Google Scholar] [CrossRef]
- Keen, C.L.; Ensunsa, J.L.; Clegg, M.S. Manganese metabolism in animals and humans including the toxicity of manganese. Met. Ions Biol. Syst. 2000, 37, 89–121. [Google Scholar]
- Perl, D.P.; Olanow, C.W. The neuropathology of manganese-induced parkinsonism. J. Neuropathol. Exp. Neurol. 2007, 66, 675–682. [Google Scholar] [CrossRef]
- Gorell, J.M.; Johnson, C.C.; Rybicki, B.A.; Peterson, E.L.; Kortsha, G.X.; Brown, G.G.; Richardson, R.J. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson’s disease. Neurotoxicology 1999, 20, 239–247. [Google Scholar]
- Prohaska, J.R. Functions of trace elements in brain metabolism. Physiol. Rev. 1987, 67, 858–901. [Google Scholar]
- Bowman, A.B.; Kwakye, G.F.; Herrero Hernández, E.; Aschner, M. Role of manganese in neurodegenerative diseases. J. Trace Elem. Med. Biol. 2011, 25, 191–203. [Google Scholar] [CrossRef]
- Lucchini, R.G.; Guazzetti, S.; Zoni, S.; Benedetti, C.; Fedrighi, C.; Peli, M.; Donna, F.; Bontempi, E.; Borgese, L.; Micheletti, S. Neurofunctional dopaminergic impairment in elderly after lifetime exposure to manganese. Neurotoxicology 2014, 45, 309–317. [Google Scholar] [CrossRef]
- Hauser, R.A.; Zesiewicz, T.A.; Rosemurgy, A.S.; Martinez, C.; Olanow, C. Manganese intoxication and chronic liver failure. Ann. Neurol. 1994, 36, 871–875. [Google Scholar] [CrossRef]
- Aschner, M.; Erikson, K.M.; Hernández, E.H.; Tjalkens, R. Manganese and its role in Parkinson’s disease: From transport to neuropathology. Neuromol. Med. 2009, 11, 252–266. [Google Scholar] [CrossRef]
- Bertinet, D.B.; Tinivella, M.; Balzola, F.A.; de Francesco, A.; Davini, O.; Rizzo, L.; Massarenti, P.; Leonardi, M.A.; Balzola, F. Brain manganese deposition and blood levels in patients undergoing home parenteral nutrition. JPEN J. Parenter. Enter. Nutr. 2000, 24, 223–227. [Google Scholar] [CrossRef]
- Fitzgerald, K.; Mikalunas, V.; Rubin, H.; McCarthey, R.; Vanagunas, A.; Craig, R.M. Hypermanganesemia in patients receiving total parenteral nutrition. JPEN J. Parenter. Enter. Nutr. 1999, 23, 333–336. [Google Scholar] [CrossRef]
- Krieger, D.; Krieger, S.; Theilmann, L.; Jansen, O.; Gass, P.; Lichtnecker, H. Manganese and chronic hepatic encephalopathy. Lancet 1995, 346, 270–274. [Google Scholar] [CrossRef]
- Fitsanakis, V.A.; Zhang, N.; Anderson, J.G.; Erikson, K.M.; Avison, M.J.; Gore, J.C.; Aschner, M. Measuring brain manganese and iron accumulation in rats following 14 weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol. Sci. 2008, 103, 116–124. [Google Scholar] [CrossRef]
- Herrero Hernandez, E.; Valentini, M.C.; Discalzi, G. T1-weighted hyperintensity in basal ganglia at brain magnetic resonance imaging: Are different pathologies sharing a common mechanism? Neurotoxicology 2002, 23, 669–674. [Google Scholar] [CrossRef]
- Roth, J.A.; Garrick, M.D. Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. Biochem. Pharmacol. 2003, 66, 1–13. [Google Scholar] [CrossRef]
- Da Silva, C.J.; da Rocha, A.J.; Jeronymo, S.; Mendes, M.F.; Milani, F.T.; Maia, A.C., Jr.; Braga, F.T.; Sens, Y.A.; Miorin, L.A. A preliminary study revealing a new association in patients undergoing maintenance hemodialysis: Manganism symptoms and T1 hyperintense changes in the basal ganglia. AJNR Am. J. Neuroradiol. 2007, 28, 1474–1479. [Google Scholar] [CrossRef]
- Ohtake, T.; Kobayashi, S.; Moriya, H.; Negishi, K.; Okamoto, K.; Maesato, K.; Saito, S. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: An angiographic examination. J. Am. Soc. Nephrol. 2005, 16, 1141–1148. [Google Scholar] [CrossRef]
- Zimmer, A.T.; Biswas, P. Characterization of the aerosols resulting from arc welding processes. J. Aerosol Sci. 2001, 32, 993–1008. [Google Scholar] [CrossRef]
- Sowards, J.; Ramirez, A.; Dickinson, D.; Lippold, J. Characterization of welding fume from smaw electrodes—Part II. Weld. J. 2010, 89, 82–90. [Google Scholar]
- Long, Z.; Jiang, Y.; Li, X.; Fadel, W.; Xu, J.; Yeh, C.; Long, L.; Luo, H.; Harezlak, J.; Murdoch, J.B. Vulnerability of welders to manganese exposure—A neuroimaging study. Neurotoxicology 2014, 45, 285–292. [Google Scholar] [CrossRef]
- ACGIH. Documentation of the Threshold Limit Values and Biological Exposure Indices; American Conference of Governmental Industrial Hygienists: Cincinnati, OH, USA, 2013. [Google Scholar]
- Bin, P.; Jiang, Y.; Hu, W. Studies on mechanism and biomarkers of manganese neurotoxicity. Railw. Occup. Saf. Health Environ. Prot. 2004, 2, 024. [Google Scholar]
- Gao, Z.; Han, J.; Wei, Q.; Rao, C. A study on the grindability of waste from the ferromanganese alloy factory. J. Univ. Sci. Technol. Suzhou 2003, 3, 009. [Google Scholar]
- Chen, P.; Parmalee, N.; Aschner, M. Genetic factors and manganese-induced neurotoxicity. Front. Genet. 2014, 5, 265. [Google Scholar] [CrossRef]
- Au, C.; Benedetto, A.; Aschner, M. Manganese transport in eukaryotes: The role of DMT1. Neurotoxicology 2008, 29, 569–576. [Google Scholar] [CrossRef]
- Garrick, M.; Kuo, H.; Vargas, F.; Singleton, S.; Zhao, L.; Smith, J.; Paradkar, P.; Roth, J.; Garrick, L. Comparison of mammalian cell lines expressing distinct isoforms of divalent metal transporter 1 in a tetracycline-regulated fashion. Biochem. J. 2006, 398, 539–546. [Google Scholar]
- Gunshin, H.; Mackenzie, B.; Berger, U.V.; Gunshin, Y.; Romero, M.F.; Boron, W.F.; Nussberger, S.; Gollan, J.L.; Hediger, M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997, 388, 482–488. [Google Scholar] [CrossRef]
- He, L.; Girijashanker, K.; Dalton, T.P.; Reed, J.; Li, H.; Soleimani, M.; Nebert, D.W. ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: Characterization of transporter properties. Mol. Pharmacol. 2006, 70, 171–180. [Google Scholar] [CrossRef]
- Aschner, M.; Gannon, M. Manganese (Mn) transport across the rat blood-brain barrier: Saturable and transferrin-dependent transport mechanisms. Brain Res. Bull. 1994, 33, 345–349. [Google Scholar] [CrossRef]
- Davidsson, L.; Lonnerdal, B.; Sandstrom, B.; Kunz, C.; Keen, C.L. Identification of transferrin as the major plasma carrier protein for manganese introduced orally or intravenously or after in vitro addition in the rat. J. Nutr. 1989, 119, 1461–1464. [Google Scholar]
- Lucaciu, C.M.; Dragu, C.; Copăescu, L.; Morariu, V.V. Manganese transport through human erythrocyte membranes—An EPR Study. Biochim. Biophys. Acta 1997, 1328, 90–98. [Google Scholar] [CrossRef]
- Culotta, V.C.; Yang, M.; Hall, M.D. Manganese transport and trafficking: Lessons learned from saccharomyces cerevisiae. Eukaryot. Cell. 2005, 4, 1159–1165. [Google Scholar] [CrossRef]
- Jensen, L.T.; Carroll, M.C.; Hall, M.D.; Harvey, C.J.; Beese, S.E.; Culotta, V.C. Down-regulation of a manganese transporter in the face of metal toxicity. Mol. Biol. Cell 2009, 20, 2810–2819. [Google Scholar] [CrossRef]
- Au, C.; Benedetto, A.; Anderson, J.; Labrousse, A.; Erikson, K.; Ewbank, J.J.; Aschner, M. SMF-1, SMF-2 and SMF-3 DMT1 orthologues regulate and are regulated differentially by manganese levels in C. elegans. PLoS One 2009, 4, e7792. [Google Scholar] [CrossRef]
- Leitch, S.; Feng, M.; Muend, S.; Braiterman, L.T.; Hubbard, A.L.; Rao, R. Vesicular distribution of secretory pathway ca2-atpase isoform 1 and a role in manganese detoxification in liver-derived polarized cells. Biometals 2011, 24, 159–170. [Google Scholar] [CrossRef]
- Leyva-Illades, D.; Chen, P.; Zogzas, C.E.; Hutchens, S.; Mercado, J.M.; Swaim, C.D.; Morrisett, R.A.; Bowman, A.B.; Aschner, M.; Mukhopadhyay, S. SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its intracellular trafficking and efflux activity. J. Neurosci. 2014, 34, 14079–14095. [Google Scholar] [CrossRef]
- Madejczyk, M.S.; Ballatori, N. The iron transporter ferroportin can also function as a manganese exporter. Biochim. Biophys. Acta 2012, 1818, 651–657. [Google Scholar] [CrossRef]
- Mukhopadhyay, S.; Bachert, C.; Smith, D.R.; Linstedt, A.D. Manganese-induced trafficking and turnover of the cis-golgi glycoprotein GPP130. Mol. Biol. Cell 2010, 21, 1282–1292. [Google Scholar] [CrossRef]
- Mukhopadhyay, S.; Linstedt, A.D. Identification of a gain-of-function mutation in a golgi p-type atpase that enhances Mn2+ efflux and protects against toxicity. Proc. Natl. Acad. Sci. USA 2011, 108, 858–863. [Google Scholar] [CrossRef]
- Yin, Z.; Jiang, H.; Lee, E.Y.; Ni, M.; Erikson, K.M.; Milatovic, D.; Bowman, A.B.; Aschner, M. Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation. J. Neurochem. 2010, 112, 1190–1198. [Google Scholar] [CrossRef]
- Lechpammer, M.; Clegg, M.S.; Muzar, Z.; Huebner, P.A.; Jin, L.; Gospe, S.M. Pathology of inherited manganese transporter deficiency. Ann. Neurol. 2014, 75, 608–612. [Google Scholar] [CrossRef]
- Quadri, M.; Federico, A.; Zhao, T.; Breedveld, G.J.; Battisti, C.; Delnooz, C.; Severijnen, L.; Di Toro Mammarella, L.; Mignarri, A.; Monti, L. Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. Am. J. Hum. Genet. 2012, 90, 467–477. [Google Scholar] [CrossRef]
- Tuschl, K.; Clayton, P.T.; Gospe, S.M., Jr.; Gulab, S.; Ibrahim, S.; Singhi, P.; Aulakh, R.; Ribeiro, R.T.; Barsottini, O.G.; Zaki, M.S. Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. Am. J. Hum. Genet. 2012, 90, 457–466. [Google Scholar] [CrossRef]
- Tuschl, K.; Mills, P.B.; Parsons, H.; Malone, M.; Fowler, D.; Bitner-Glindzicz, M.; Clayton, P.T. Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia—A new metabolic disorder. J. Inherit. Metab. Dis. 2008, 31, 151–163. [Google Scholar] [CrossRef]
- Aschner, M.; Guilarte, T.R.; Schneider, J.S.; Zheng, W. Manganese: Recent advances in understanding its transport and neurotoxicity. Toxicol. Appl. Pharmacol. 2007, 221, 131–147. [Google Scholar] [CrossRef]
- Herrero Hernandez, E.; Discalzi, G.; Valentini, C.; Venturi, F.; Chio, A.; Carmellino, C.; Rossi, L.; Sacchetti, A.; Pira, E. Follow-up of patients affected by manganese-induced parkinsonism after treatment with CaNa2 EDTA. Neurotoxicology 2006, 27, 333–339. [Google Scholar] [CrossRef]
- Inoue, T.; Majid, T.; Pautler, R.G. Manganese enhanced MRI (MEMRI): Neurophysiological applications. Rev. Neurosci. 2011, 22, 675–694. [Google Scholar] [CrossRef]
- Newland, M.C.; Ceckler, T.L.; Kordower, J.H.; Weiss, B. Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Exp. Neurol. 1989, 106, 251–258. [Google Scholar] [CrossRef]
- Kumar, K.K.; Aboud, A.A.; Patel, D.K.; Aschner, M.; Bowman, A.B. Optimization of fluorescence assay of cellular manganese status for high throughput screening. J. Biochem. Mol. Toxicol. 2013, 27, 42–49. [Google Scholar] [CrossRef]
- Kwakye, G.F.; Li, D.; Bowman, A.B. Novel high-throughput assay to assess cellular manganese levels in a striatal cell line model of Huntington’s disease confirms a deficit in manganese accumulation. Neurotoxicology 2011, 32, 630–639. [Google Scholar] [CrossRef]
- Kwakye, G.F.; Li, D.; Kabobel, O.A.; Bowman, A.B. Cellular Fura-2 manganese extraction assay (CFMEA). Curr. Protoc. Toxicol. 2011, 2011. [Google Scholar] [CrossRef]
- Finkelstein, M.M.; Jerrett, M. A Study of the relationships between Parkinson’s disease and markers of traffic-derived and environmental manganese air pollution in two canadian cities. Environ. Res. 2007, 104, 420–432. [Google Scholar] [CrossRef]
- Lucchini, R.G.; Albini, E.; Benedetti, L.; Borghesi, S.; Coccaglio, R.; Malara, E.C.; Parrinello, G.; Garattini, S.; Resola, S.; Alessio, L. High prevalence of Parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries. Am. J. Ind. Med. 2007, 50, 788–800. [Google Scholar] [CrossRef]
- Mergler, D. Neurotoxic effects of low level exposure to manganese in human populations. Environ. Res. 1999, 80, 99–102. [Google Scholar] [CrossRef]
- Pal, P.K.; Samii, A.; Calne, D.B. Manganese neurotoxicity: A review of clinical features, imaging and pathology. Neurotoxicology 1999, 20, 227–238. [Google Scholar]
- Rodríguez-Agudelo, Y.; Riojas-Rodríguez, H.; Ríos, C.; Rosas, I.; Sabido Pedraza, E.; Miranda, J.; Siebe, C.; Texcalac, J.L.; Santos-Burgoa, C. Motor alterations associated with exposure to manganese in the environment in Mexico. Sci. Total Environ. 2006, 368, 542–556. [Google Scholar] [CrossRef]
- Nong, A.; Teeguarden, J.G.; Clewell, H.J., III; Dorman, D.C.; Andersen, M.E. Pharmacokinetic modeling of manganese in the rat IV: Assessing factors that contribute to brain accumulation during inhalation exposure. J. Toxicol. Environ. Health A 2008, 71, 413–426. [Google Scholar] [CrossRef]
- Nong, A.; Taylor, M.D.; Clewell, H.J., 3rd; Dorman, D.C.; Andersen, M.E. Manganese tissue dosimetry in rats and monkeys: Accounting for dietary and inhaled Mn with physiologically based pharmacokinetic modeling. Toxicol. Sci. 2009, 108, 22–34. [Google Scholar] [CrossRef]
- Yoon, M.; Nong, A.; Clewell, H.J., 3rd; Taylor, M.D.; Dorman, D.C.; Andersen, M.E. Evaluating placental transfer and tissue concentrations of manganese in the pregnant rat and fetuses after inhalation exposures with a PBPK model. Toxicol. Sci. 2009, 112, 44–58. [Google Scholar] [CrossRef]
- Yoon, M.; Nong, A.; Clewell, H.J.; Taylor, M.D.; Dorman, D.C.; Andersen, M.E. Lactational transfer of manganese in rats: Predicting manganese tissue concentration in the dam and pups from inhalation exposure with a pharmacokinetic model. Toxicol. Sci. 2009, 112, 23–43. [Google Scholar] [CrossRef]
- Schroeter, J.D.; Nong, A.; Yoon, M.; Taylor, M.D.; Dorman, D.C.; Andersen, M.E.; Clewell, H.J., 3rd. Analysis of manganese tracer kinetics and target tissue dosimetry in monkeys and humans with multi-route physiologically based pharmacokinetic models. Toxicol. Sci. 2011, 120, 481–498. [Google Scholar] [CrossRef]
- Andersen, M.E.; Dorman, D.C.; Clewell, H.J., III; Taylor, M.D.; Nong, A. Multi-dose-route, multi-species pharmacokinetic models for manganese and their use in risk assessment. J. Toxicol. Environ. Health A 2010, 73, 217–234. [Google Scholar] [CrossRef]
- Eichenberger, E. The interrelation between essentiality and toxicity of metals in the aquatic ecosystem. Met. Ions Biol. Syst. 1986, 20, 67–100. [Google Scholar]
- Nordberg, G.F.; Sandstrom, B.; Becking, G.; Goyer, R.A. Essentiality and toxicity of metals. In Heavy Metals in the Environment; Marcel Dekker, Inc.: New York, NY, USA, 2002; pp. 1–34. [Google Scholar]
- Wang, X.; Yang, Y.; Wang, X.; Xu, S. The effect of occupational exposure to metals on the nervous system function in welders. J. Occup. Health 2006, 48, 100–106. [Google Scholar] [CrossRef]
- Kuroda, Y.; Kawahara, M. Aggregation of amyloid beta-protein and its neurotoxicity: Enhancement by aluminum and other metals. Tohoku J. Exp. Med. 1994, 174, 263–268. [Google Scholar] [CrossRef]
- Mantyh, P.W.; Ghilardi, J.R.; Rogers, S.; DeMaster, E.; Allen, C.J.; Stimson, E.R.; Maggio, J.E. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J. Neurochem. 1993, 61, 1171–1174. [Google Scholar] [CrossRef]
- Uversky, V.N.; Li, J.; Bower, K.; Fink, A.L. Synergistic effects of pesticides and metals on the fibrillation of α-synuclein: Implications for Parkinson’s disease. Neurotoxicology 2002, 23, 527–536. [Google Scholar] [CrossRef]
- Uversky, V.N.; Li, J.; Fink, A.L. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson’s disease and heavy metal exposure. J. Biol. Chem. 2001, 276, 44284–44296. [Google Scholar] [CrossRef]
- Couper, J. On the effects of black oxide of manganese when inhaled into the lungs. Br. Ann. Med. Pharmacol. 1837, 1, 41–42. [Google Scholar]
- Bouabid, S.; Delaville, C.; de Deurwaerdère, P.; Lakhdar-Ghazal, N.; Benazzouz, A. Manganese-induced atypical parkinsonism is associated with altered basal ganglia activity and changes in tissue levels of monoamines in the rat. PLoS One 2014, 9. [Google Scholar] [CrossRef]
- Dietz, M.; Ihrig, A.; Wrazidlo, W.; Bader, M.; Jansen, O.; Triebig, G. Results of magnetic resonance imaging in long-term manganese dioxide-exposed workers. Environ. Res. 2001, 85, 37–40. [Google Scholar] [CrossRef]
- Josephs, K.A.; Ahlskog, J.E.; Klos, K.J.; Kumar, N.; Fealey, R.D.; Trenerry, M.R.; Cowl, C.T. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology 2005, 64, 2033–2039. [Google Scholar] [CrossRef]
- Klos, K.; Chandler, M.; Kumar, N.; Ahlskog, J.; Josephs, K. Neuropsychological profiles of manganese neurotoxicity. Eur. J. Neurol. 2006, 13, 1139–1141. [Google Scholar] [CrossRef]
- Uchino, A.; Noguchi, T.; Nomiyama, K.; Takase, Y.; Nakazono, T.; Nojiri, J.; Kudo, S. Manganese accumulation in the brain: MR imaging. Neuroradiology 2007, 49, 715–720. [Google Scholar] [CrossRef]
- Bakthavatsalam, S.; Das Sharma, S.; Sonawane, M.; Thirumalai, V.; Datta, A. A zebrafish model of manganism reveals reversible and treatable symptoms that are independent of neurotoxicity. Dis. Model. Mech. 2014, 7, 1239–1251. [Google Scholar] [CrossRef]
- Scholten, J.M. On Manganese encephalopathy: Description of a case. Folia. Psychiatr. Neurol. Neurochir. Neerl. 1953, 56, 878–884. [Google Scholar]
- Racette, B.A. Manganism in the 21st century: The hanninen lecture. Neurotoxicology 2014, 45, 201–207. [Google Scholar] [CrossRef]
- Guilarte, T.R. Manganese and Parkinson’s disease: A critical review and new findings. Environ. Health Perspect. 2010, 118, 1071–1080. [Google Scholar] [CrossRef]
- Pal, P.; Calne, S.; Samii, A.; Fleming, J. A review of normal sleep and its disturbances in Parkinson’s disease. Parkinsonism Relat. Disord. 1999, 5, 1–17. [Google Scholar] [CrossRef]
- Calne, D.B.; Chu, N.S.; Huang, C.C.; Lu, C.S.; Olanow, W. Manganism and idiopathic Parkinsonism: Similarities and differences. Neurology 1994, 44, 1583–1586. [Google Scholar] [CrossRef]
- Olanow, C.W. Manganese-induced Parkinsonism and Parkinson’s disease. Ann. N. Y. Acad. Sci. 2004, 1012, 209–223. [Google Scholar] [CrossRef]
- Emara, A.M.; el-Ghawabi, S.H.; Madkour, O.I.; el-Samra, G.H. Chronic manganese poisoning in the dry battery industry. Br. J. Ind. Med. 1971, 28, 78–82. [Google Scholar] [CrossRef]
- Rodier, J. Manganese poisoning in moroccan miners. Br. J. Ind. Med. 1955, 12, 21–35. [Google Scholar] [CrossRef]
- Neve, K. The Dopamine Receptors; Springer: Berlin, Germany, 2009. [Google Scholar]
- Vallone, D.; Picetti, R.; Borrelli, E. Structure and function of dopamine receptors. Neurosci. Biobehav. Rev. 2000, 24, 125–132. [Google Scholar] [CrossRef]
- Dodd, C.A.; Bloomquist, J.R.; Klein, B.G. Consequences of manganese administration for striatal dopamine and motor behavior in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed C57BL/6 mice. Hum. Exp. Toxicol. 2013, 32, 865–880. [Google Scholar] [CrossRef]
- Erikson, K.; Aschner, M. Manganese causes differential regulation of glutamate transporter (GLAST) taurine transporter and metallothionein in cultured rat astrocytes. Neurotoxicology 2002, 23, 595–602. [Google Scholar] [CrossRef]
- Madison, J.L.; Wegrzynowicz, M.; Aschner, M.; Bowman, A.B. Disease-toxicant interactions in manganese exposed huntington disease mice: Early changes in striatal neuron morphology and dopamine metabolism. PLoS One 2012, 7, e31024. [Google Scholar] [CrossRef]
- Seth, P.K.; Chandra, S.V. Neurotransmitters and neurotransmitter receptors in developing and adult rats during manganese poisoning. Neurotoxicology 1984, 5, 67–76. [Google Scholar]
- Calabresi, P.; Ammassari-Teule, M.; Gubellini, P.; Sancesario, G.; Morello, M.; Centonze, D.; Marfia, G.A.; Saulle, E.; Passino, E.; Picconi, B. A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication. Neurobiol. Dis. 2001, 8, 419–432. [Google Scholar] [CrossRef]
- Normandin, L.; Hazell, A.S. Manganese neurotoxicity: An update of pathophysiologic mechanisms. Metab. Brain Dis. 2002, 17, 375–387. [Google Scholar] [CrossRef]
- Eriksson, H.; Lenngren, S.; Heilbronn, E. Effect of long-term administration of manganese on biogenic amine levels in discrete striatal regions of rat brain. Arch. Toxicol. 1987, 59, 426–431. [Google Scholar] [CrossRef]
- Tomás-Camardiel, M.; Herrera, A.J.; Venero, J.L.; Cruz Sánchez-Hidalgo, M.; Cano, J.; Machado, A. Differential regulation of glutamic acid decarboxylase mRNA and tyrosine hydroxylase mRNA expression in the aged manganese-treated rats. Mol. Brain Res. 2002, 103, 116–129. [Google Scholar] [CrossRef]
- Autissier, N.; Rochette, L.; Dumas, P.; Beley, A.; Loireau, A.; Bralet, J. Dopamine and norepinephrine turnover in various regions of the rat brain after chronic manganese chloride administration. Toxicology 1982, 24, 175–182. [Google Scholar] [CrossRef]
- Dıaz-Véliz, G.; Mora, S.; Gómez, P.; Dossi, M.T.; Montiel, J.; Arriagada, C.; Aboitiz, F.; Segura-Aguilar, J. Behavioral effects of manganese injected in the rat substantia nigra are potentiated by dicumarol, a DT-diaphorase inhibitor. Pharmacol. Biochem. Behav. 2004, 77, 245–251. [Google Scholar] [CrossRef]
- Sistrunk, S.C.; Ross, M.K.; Filipov, N.M. Direct effects of manganese compounds on dopamine and its metabolite dopac: An in vitro study. Environ. Toxicol. Pharmacol. 2007, 23, 286–296. [Google Scholar] [CrossRef]
- Chandra, S.; Shukla, G. Concentrations of striatal catecholamines in rats given manganese chloride through drinking water. J. Neurochem. 1981, 36, 683–687. [Google Scholar] [CrossRef]
- Tran, T.T.; Chowanadisai, W.; Crinella, F.M.; Chicz-DeMet, A.; Lönnerdal, B. Effect of high dietary manganese intake of neonatal rats on tissue mineral accumulation, striatal dopamine levels, and neurodevelopmental status. Neurotoxicology 2002, 23, 635–643. [Google Scholar] [CrossRef]
- Guilarte, T.R.; Burton, N.C.; McGlothan, J.L.; Verina, T.; Zhou, Y.; Alexander, M.; Pham, L.; Griswold, M.; Wong, D.F.; Syversen, T. Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): Implications to manganese-induced parkinsonism. J. Neurochem. 2008, 107, 1236–1247. [Google Scholar] [CrossRef]
- Chen, M.; Lee, J.; McGlothan, J.L.; Furukawa, E.; Adams, R.J.; Alexander, M.; Wong, D.F.; Guilarte, T.R. Acute manganese administration alters dopamine transporter levels in the non-human primate striatum. Neurotoxicology 2006, 27, 229–236. [Google Scholar] [CrossRef]
- Roth, J.A.; Li, Z.; Sridhar, S.; Khoshbouei, H. The effect of manganese on dopamine toxicity and dopamine transporter (DAT) in control and DAT transfected HEK cells. Neurotoxicology 2013, 35, 121–128. [Google Scholar] [CrossRef]
- Huang, C. Parkinsonism induced by chronic manganese intoxication—An experience in Taiwan. Chang Gung Med. J. 2007, 30, 385. [Google Scholar]
- Kessler, K.R.; Wunderlich, G.; Hefter, H.; Seitz, R.J. Secondary progressive chronic manganism associated with markedly decreased striatal D2 receptor density. Mov. Disorder. 2003, 18, 217–219. [Google Scholar] [CrossRef]
- Tarazi, F.I.; Tomasini, E.C.; Baldessarini, R.J. Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: An autoradiographic study. Dev. Neurosci. 1999, 21, 43–49. [Google Scholar] [CrossRef]
- Felicio, A.C.; Shih, M.C.; Godeiro-Junior, C.; Andrade, L.A.; Bressan, R.A.; Ferraz, H.B. Molecular imaging studies in Parkinson disease: Reducing diagnostic uncertainty. Neurologist 2009, 15, 6–16. [Google Scholar] [CrossRef]
- Leenders, K.L. Significance of non-presynaptic SPECT tracer methods in Parkinson’s disease. Mov. Disord. 2003, 18, S39–S42. [Google Scholar] [CrossRef]
- Rogers, K.; Beaubrun, I.; Catapane, E.; Carroll, M. The toxic effects of manganese on dopamine D2 receptor activation is not due to inactivation of the phospholipase c receptor signal transduction component (1143.7). FASEB J. 2014, 28, 1143.7. [Google Scholar]
- Cummings, J.L.; Henchcliffe, C.; Schaier, S.; Simuni, T.; Waxman, A.; Kemp, P. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain 2011, 134, 3146–3166. [Google Scholar] [CrossRef]
- Laruelle, M.; Baldwin, R.M.; Malison, R.T.; Zea-Ponce, Y.; Zoghbi, S.S.; Al-Tikeriti, M.S.; Sybirska, E.H.; Zimmermann, R.C.; Wisniewski, G.; Neumeyer, J.L. SPECT imaging of dopamine and serotonin transporters with [123I]β-CIT: Pharmacological characterization of brain uptake in nonhuman primates. Synapse 1993, 13, 295–309. [Google Scholar] [CrossRef]
- Kim, Y.; Kim, J.; Kim, J.; Yoo, C.; Lee, C.; Lee, J.; Kim, H.; Yang, S.; Chung, H.; Lee, D. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: What does it mean? Mov. Disord. 2002, 17, 568–575. [Google Scholar] [CrossRef]
- Struve, M.F.; McManus, B.E.; Wong, B.A.; Dorman, D.C. Basal ganglia neurotransmitter concentrations in rhesus monkeys following subchronic manganese sulfate inhalation. Am. J. Ind. Med. 2007, 50, 772–778. [Google Scholar] [CrossRef]
- Burton, N.C.; Guilarte, T.R. Manganese neurotoxicity: Lessons learned from longitudinal studies in non-human primates. Environ. Health Perspect. 2009, 117, 325–332. [Google Scholar] [CrossRef]
- Eriksson, H.; Gillberg, P.; Aquilonius, S.; Hedström, K.; Heilbronn, E. Receptor alterations in manganese intoxicated monkeys. Arch. Toxicol. 1992, 66, 359–364. [Google Scholar] [CrossRef]
- Bonilla, E. Increased GABA content in caudate nucleus of rats after chronic manganese chloride administration. J. Neurochem. 1978, 31, 551–552. [Google Scholar] [CrossRef]
- Garcia, S.J.; Gellein, K.; Syversen, T.; Aschner, M. Iron Deficient and manganese supplemented diets alter metals and transporters in the developing rat brain. Toxicol. Sci. 2007, 95, 205–214. [Google Scholar] [CrossRef]
- Garcia, S.J.; Gellein, K.; Syversen, T.; Aschner, M. A Manganese-enhanced diet alters brain metals and transporters in the developing rat. Toxicol. Sci. 2006, 92, 516–525. [Google Scholar] [CrossRef]
- Gwiazda, R.; Lee, D.; Sheridan, J.; Smith, D. Low cumulative manganese exposure affects striatal GABA but not dopamine. Neurotoxicology 2002, 23, 69–76. [Google Scholar] [CrossRef]
- Lipe, G.W.; Duhart, H.; Newport, G.D.; Slikker, W., Jr.; Ali, S.F. Effect of manganese on the concentration of amino acids in different regions of the rat brain. J. Environ. Sci. Health B 1999, 34, 119–132. [Google Scholar] [CrossRef]
- Reaney, S.H.; Bench, G.; Smith, D.R. Brain accumulation and toxicity of Mn(II) and Mn(III) exposures. Toxicol. Sci. 2006, 93, 114–124. [Google Scholar] [CrossRef]
- Anderson, J.G.; Fordahl, S.C.; Cooney, P.T.; Weaver, T.L.; Colyer, C.L.; Erikson, K.M. Manganese exposure alters extracellular GABA, GABA receptor and transporter protein and mRNA levels in the developing rat brain. Neurotoxicology 2008, 29, 1044–1053. [Google Scholar] [CrossRef]
- Edden, R.A.; Barker, P.B. Spatial effects in the detection of Γ-aminobutyric acid: Improved sensitivity at high fields using inner volume saturation. Magn. Reson. Med. 2007, 58, 1276–1282. [Google Scholar] [CrossRef]
- Dydak, U.; Jiang, Y.; Long, L.; Zhu, H.; Chen, J.; Li, W.; Edden, R.A.; Hu, S.; Fu, X.; Long, Z. In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ. Health Perspect. 2010, 119, 219–224. [Google Scholar] [CrossRef] [Green Version]
- Maciejewski, P.K.; Rothman, D.L. Proposed cycles for functional glutamate trafficking in synaptic neurotransmission. Neurochem. Int. 2008, 52, 809–825. [Google Scholar] [CrossRef]
- Bergles, D.E.; Jahr, C.E. Synaptic activation of glutamate transporters in hippocampal astrocytes. Neuron 1997, 19, 1297–1308. [Google Scholar] [CrossRef]
- Danbolt, N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65, 1–105. [Google Scholar] [CrossRef]
- Spadoni, F.; Stefani, A.; Morello, M.; Lavaroni, F.; Giacomini, P.; Sancesario, G. Selective vulnerability of pallidal neurons in the early phases of manganese intoxication. Exp. Brain Res. 2000, 135, 544–551. [Google Scholar] [CrossRef]
- Centonze, D.; Picconi, B.; Gubellini, P.; Bernardi, G.; Calabresi, P. Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur. J. Neurosci. 2001, 13, 1071–1077. [Google Scholar] [CrossRef]
- Castilho, R.F.; Ward, M.W.; Nicholls, D.G. Oxidative stress, mitochondrial function, and acute glutamate excitotoxicity in cultured cerebellar granule cells. J. Neurochem. 1999, 72, 1394–1401. [Google Scholar] [CrossRef]
- Gavin, C.E.; Gunter, K.K.; Gunter, T.E. Manganese and calcium transport in mitochondria: Implications for manganese toxicity. Neurotoxicology 1999, 20, 445–453. [Google Scholar]
- Zwingmann, C.; Leibfritz, D.; Hazell, A.S. Brain energy metabolism in a sub-acute rat model of manganese neurotoxicity: An ex vivo nuclear magnetic resonance study using [1–13C] Glucose. Neurotoxicology 2004, 25, 573–587. [Google Scholar] [CrossRef]
- Zwingmann, C.; Leibfritz, D.; Hazell, A.S. Energy metabolism in astrocytes and neurons treated with manganese & colon; relation among cell-specific energy failure, glucose metabolism, and intercellular trafficking using multinuclear NMR-spectroscopic analysis. J. Cereb. Blood Flow Metab. 2003, 23, 756–771. [Google Scholar]
- Cano, G.; Suarez-Roca, H.; Bonilla, E. Manganese poisoning reduces strychnine-insensitive glycine binding sites in the globus pallidus of the mouse brain. Invest. Clin. 1996, 37, 209–219. [Google Scholar]
- Fairfax, R.E.; Franek, B. OSHA compliance issues: Manganese exposure during welding operations. Appl. Occup. Environ. Hyg. 1994, 9, 537–538. [Google Scholar] [CrossRef]
- Cotzias, G.C.; Papavasiliou, P.S.; Gellene, R. Modification of Parkinsonism—Chronic treatment with l-Dopa. N. Engl. J. Med. 1969, 280, 337–345. [Google Scholar] [CrossRef]
- Lang, A.E.; Lozano, A.M. Parkinson’s disease. N. Engl. J. Med. 1998, 339, 1044–1053. [Google Scholar] [CrossRef]
- Nutt, J.G.; Woodward, W.R.; Hammerstad, J.P.; Carter, J.H.; Anderson, J.L. The on-off phenomenon in Parkinson’s disease: Relation to levodopa absorption and transport. N. Engl. J. Med. 1984, 310, 483–488. [Google Scholar] [CrossRef]
- Nutt, J.G.; Rufener, S.L.; Carter, J.H.; Anderson, V.C.; Pahwa, R.; Hammerstad, J.P.; Burchiel, K.J. Interactions between deep brain stimulation and levodopa in Parkinson’s disease. Neurology 2001, 57, 1835–1842. [Google Scholar] [CrossRef]
- Fahn, S. The spectrum of levodopa-induced dyskinesias. Ann. Neurol. 2000, 47, S2–S11. [Google Scholar]
- Forno, L.S. Neuropathology of Parkinson’s disease. J. Neuropathol. Exp. Neurol. 1996, 55, 259–272. [Google Scholar] [CrossRef]
- Golbe, L.I. Young-onset Parkinson’s disease: A clinical review. Neurology 1991, 41, 168–173. [Google Scholar] [CrossRef]
- Hickey, P.; Stacy, M. Available and emerging treatments for Parkinson’s disease: A review. Drug Des. Dev. Ther. 2011, 5, 241–254. [Google Scholar]
- Jellinger, K.A. The role of iron in neurodegeneration. Drugs Aging 1999, 14, 115–140. [Google Scholar] [CrossRef]
- Koller, W.C.; Lyons, K.E.; Truly, W. Effect of levodopa treatment for Parkinsonism in welders: A double-blind study. Neurology 2004, 62, 730–733. [Google Scholar] [CrossRef]
- Sadek, A.H.; Rauch, R.; Schulz, P.E. Parkinsonism due to manganism in a welder. Int. J. Toxicol. 2003, 22, 393–401. [Google Scholar] [CrossRef]
- Lloyd, R.V. Mechanism of the manganese-catalyzed autoxidation of dopamine. Chem. Res. Toxicol. 1995, 8, 111–116. [Google Scholar] [CrossRef]
- Parenti, M.; Rusconi, L.; Cappabianca, V.; Parati, E.A.; Groppetti, A. Role of dopamine in manganese neurotoxicity. Brain Res. 1988, 473, 236–240. [Google Scholar] [CrossRef]
- Discalzi, G.; Pira, E.; Herrero Hernandez, E.; Valentini, C.; Turbiglio, M.; Meliga, F. Occupational Mn Parkinsonism: Magnetic resonance imaging and clinical patterns following CaNa2-EDTA chelation. Neurotoxicology 2000, 21, 863–866. [Google Scholar]
- Jiang, Y.M.; Mo, X.A.; Du, F.Q.; Fu, X.; Zhu, X.Y.; Gao, H.Y.; Xie, J.L.; Liao, F.L.; Pira, E.; Zheng, W. Effective treatment of manganese-induced occupational parkinsonism with P-aminosalicylic acid: A case of 17-year follow-up study. J. Occup. Environ. Med. 2006, 48, 644–649. [Google Scholar] [CrossRef]
- Ky, S.Q.; Deng, H.S.; Xie, P.Y.; Hu, W. A report of two cases of chronic serious manganese poisoning treated with sodium para-aminosalicylic acid. Br. J. Ind. Med. 1992, 49, 66–69. [Google Scholar] [CrossRef]
- Ojo, C.; Rogers, K.; Adams, T.; Catapane, E.J.; Carroll, M.A. Chelating agents reverse neurotoxic effects of manganese on dopaminergic innervation of gill of the bivalve mollusc crassostrea virginica. FASEB J. 2013, 27, 1179.3. [Google Scholar]
- Ono, K.; Komai, K.; Yamada, M. Myoclonic involuntary movement associated with chronic manganese poisoning. J. Neurol. Sci. 2002, 199, 93–96. [Google Scholar] [CrossRef]
- Zheng, W.; Jiang, Y.; Zhang, Y.; Jiang, W.; Wang, X.; Cowan, D.M. Chelation therapy of manganese intoxication with para-aminosalicylic acid (PAS) in sprague–dawley rats. Neurotoxicology 2009, 30, 240–248. [Google Scholar] [CrossRef]
- Foglieni, C.; Fulgenzi, A.; Ticozzi, P.; Pellegatta, F.; Sciorati, C.; Belloni, D.; Ferrero, E.; Ferrero, M.E. Protective effect of EDTA preadministration on renal ischemia. BMC Nephrology 2006, 7. [Google Scholar] [CrossRef]
- Nachtman, J.P.; Delor, S.; Brennan, C.E. Manganese neurotoxicity: Effects of varying oxygen tension and EDTA on dopamine auto-oxidation. Neurotoxicology 1987, 8, 249–253. [Google Scholar]
- De Paris, P.; Caroldi, S. In vivo inhibition of serum dopamine-beta-hydroxylase by CaNa2 EDTA injection. Hum. Exp. Toxicol. 1994, 13, 253–256. [Google Scholar] [CrossRef]
- Kosai, M.; Boyle, A. Ethylenediaminetetraacetic acid in manganese poisoning of rats. Ind. Med. Surg. 1956, 25, 1–3. [Google Scholar]
- Crossgrove, J.; Zheng, W. Manganese toxicity upon overexposure. NMR Biomed. 2004, 17, 544–553. [Google Scholar] [CrossRef]
- Huang, C.; Chu, N.; Lu, C.; Wang, J.; Tsai, J.; Tzeng, J.; Wolters, E.C.; Calne, D.B. Chronic manganese intoxication. Arch. Neurol. 1989, 46, 1104–1106. [Google Scholar] [CrossRef]
- Yamada, M.; Ohno, S.; Okayasu, I.; Okeda, R.; Hatakeyama, S.; Watanabe, H.; Ushio, K.; Tsukagoshi, H. Chronic manganese poisoning: A neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol. 1986, 70, 273–278. [Google Scholar] [CrossRef]
- Cook, D.G.; Fahn, S.; Brait, K.A. Chronic manganese intoxication. Arch. Neurol. 1974, 30, 59–64. [Google Scholar] [CrossRef]
- Marreilha dos Santos, A.; Lucas, R.L.; Andrade, V.; Mateus, M.L.; Milatovic, D.; Aschner, M.; Batoreu, M. Protective effects of ebselen (Ebs) and para-aminosalicylic acid (PAS) against manganese (Mn)-induced neurotoxicity. Toxicol. Appl. Pharmacol. 2012, 258, 394–402. [Google Scholar] [CrossRef]
- Wang, F.; Wang, C.; Jiang, Y.; Deng, X.; Lu, J.; Ou, S. Protective role of sodium para-amino salicylic acid against manganese-induced hippocampal neurons damage. Environ. Toxicol. Pharmacol. 2014, 37, 1071–1078. [Google Scholar] [CrossRef]
- Yuan, H.; Zhang, Z.; Liang, L.; Shen, Q.; Wang, X.; Ren, S.; Ma, H.; Jiao, S.; Liu, P. Treatment strategies for Parkinson’s disease. Neurosci. Bull. 2010, 26, 66–76. [Google Scholar] [CrossRef]
- Bloem, B.R.; Beckley, D.J.; van Dijk, J.G.; Zwinderman, A.H.; Remler, M.P.; Roos, R.A. Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson’s disease. Mov. Disord. 1996, 11, 509–521. [Google Scholar] [CrossRef]
- Bohnen, N.I.; Cham, R. Postural control, gait, and dopamine functions in Parkinsonian movement disorders. Clin. Geriatr. Med. 2006, 22, 797–812. [Google Scholar] [CrossRef]
- Pahwa, R. Understanding Parkinson’s disease: An update on current diagnostic and treatment strategies. J. Am. Med. Dir. Assoc. 2006, 7, 4–10. [Google Scholar]
- Chen, H.; Mosley, T.H.; Alonso, A.; Huang, X. Plasma urate and Parkinson’s disease in the atherosclerosis risk in communities (ARIC) study. Am. J. Epidemiol. 2009, 169, 1064–1069. [Google Scholar] [CrossRef]
- Uzun, M.; Alp, R.; Uzlu, E.; Alp, S.; Citil, M.; Topcu, B.; Erdogan, H. Investigation of oral selegiline and rasagiline administration on qt interval in conscious rabbits. Eur. Rev. Med. Pharmacol. Sci. 2009, 13, 95–98. [Google Scholar]
- Weinreb, O.; Amit, T.; Sagi, Y.; Drigues, N.; Youdim, M.B. Genomic and proteomic study to survey the mechanism of action of the anti-parkinson’s disease drug, rasagiline compared with selegiline, in the rat midbrain. J. Neural Transm. 2009, 116, 1457–1472. [Google Scholar] [CrossRef]
- Follett, K.A.; Weaver, F.M.; Stern, M.; Hur, K.; Harris, C.L.; Luo, P.; Marks, W.J., Jr.; Rothlind, J.; Sagher, O.; Moy, C. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N. Engl. J. Med. 2010, 362, 2077–2091. [Google Scholar] [CrossRef]
- Lyons, K.E.; Pahwa, R. Deep brain stimulation and tremor. Neurotherapeutics 2008, 5, 331–338. [Google Scholar] [CrossRef]
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kwakye, G.F.; Paoliello, M.M.B.; Mukhopadhyay, S.; Bowman, A.B.; Aschner, M. Manganese-Induced Parkinsonism and Parkinson’s Disease: Shared and Distinguishable Features. Int. J. Environ. Res. Public Health 2015, 12, 7519-7540. https://doi.org/10.3390/ijerph120707519
Kwakye GF, Paoliello MMB, Mukhopadhyay S, Bowman AB, Aschner M. Manganese-Induced Parkinsonism and Parkinson’s Disease: Shared and Distinguishable Features. International Journal of Environmental Research and Public Health. 2015; 12(7):7519-7540. https://doi.org/10.3390/ijerph120707519
Chicago/Turabian StyleKwakye, Gunnar F., Monica M.B. Paoliello, Somshuvra Mukhopadhyay, Aaron B. Bowman, and Michael Aschner. 2015. "Manganese-Induced Parkinsonism and Parkinson’s Disease: Shared and Distinguishable Features" International Journal of Environmental Research and Public Health 12, no. 7: 7519-7540. https://doi.org/10.3390/ijerph120707519